Covariate Selection Under Sparse Individual Information

Why Individual Information Matters in Covariate Selection

A population pharmacokinetic model can estimate a covariate effect without estimating each subject’s parameter precisely. It uses the concentration data across subjects and accounts for between-subject variability. Nevertheless, sparse or poorly timed samples often leave less information about individual parameters. That loss can widen uncertainty about a covariate effect, reduce the power of its test, and make the ordering of candidate covariates less dependable.

The key distinction is between the number of subjects and the information contributed by their observations. A large study can still have weak information for a particular effect if individual parameters are poorly informed, the covariate varies little, or the covariate values are associated with substantial differences in information. Sparse sampling is not automatically uninformative: a few well-timed concentrations may be more useful for a parameter than a larger number of observations at uninformative times.

Definition: Individual information is the information in one subject’s observations about that subject’s model parameters, conditional on the model and design. Covariate-effect precision describes how tightly the population data estimate a covariate coefficient, commonly summarized by its standard error. Sparse individual information can reduce covariate-effect precision, but the size of that reduction also depends on covariate variation, the population variability model, and the relationship between information and covariate values.

A Working Information Approximation

Consider a continuous, centered covariate \(z_i\) and a parameter whose typical value depends on that covariate. On the log-parameter scale, let the covariate coefficient be \(\beta\), so that a one-unit increase in \(z_i\) corresponds to a \(\beta\)-unit change in the typical log parameter. A useful local approximation represents the information about subject \(i\)’s log parameter from their concentration data as a noisy measurement:

y_i = a + \beta z_i + u_i,\qquad u_i\sim N(0,v_i),\qquad v_i=\omega^2+s_i^2.

Here \(a\) is an intercept, \(\omega^2\) is the between-subject variance on this scale, and \(s_i^2\) approximates the uncertainty in subject \(i\)’s parameter information from their concentration data. The approximation assumes independent subjects, a correctly specified linear covariate relationship on the chosen scale, and locally normal errors with known or adequately estimated \(v_i\). It is a way to understand information, not a replacement for fitting the population model to concentration data. In particular, \(y_i\) should not be treated as an observed empirical Bayes estimate with error-free precision.

Writing \(w_i=1/v_i\), the approximate log likelihood for \(a\) and \(\beta\), apart from a constant, is a weighted sum of squared residuals. Its curvature gives the information matrix. When the intercept is also estimated, the information available for the slope after accounting for that intercept is:

I_{\beta\mid a} = \sum_{i=1}^{n}w_i(z_i-\bar z_w)^2, \qquad \bar z_w=\frac{\sum_{i=1}^{n}w_i z_i}{\sum_{i=1}^{n}w_i}.

This formula shows two routes to weak covariate-effect information. If \(v_i\) is large, the subject’s weight \(w_i\) is small. If the covariate values have little weighted variation, there is little information for distinguishing a slope from an intercept. Under the approximation, the standard error of the estimated coefficient is \(SE(\hat\beta)\approx 1/\sqrt{I_{\beta\mid a}}\). In a nonlinear population model, the actual information also depends on the concentration-time design, residual error, parameter correlations, and other estimated model components. The formula is therefore a diagnostic guide, not a universal exact standard error formula.

Worked Examples

Worked Example: How Lower Individual Information Widens an Effect Estimate

Suppose a hypothetical study has a centered covariate with \(\sum_i z_i^2=20\), and assume every subject has the same approximate concentration-data uncertainty. Let \(\omega^2=0.09\). Compare a relatively informative design with \(s_i^2=0.04\) to a sparse, less informative design with \(s_i^2=0.36\). Assume the covariate is balanced so that the intercept does not reduce the stated sum of squares.

With the more informative design, \(v_i=0.09+0.04=0.13\). Thus:

I_{\beta\mid a}=\frac{20}{0.13}=153.8,\qquad SE(\hat\beta)\approx\frac{1}{\sqrt{153.8}}=0.08062.

With the sparser design, \(v_i=0.09+0.36=0.45\), giving:

I_{\beta\mid a}=\frac{20}{0.45}=44.44,\qquad SE(\hat\beta)\approx\frac{1}{\sqrt{44.44}}=0.1500.

If the estimated coefficient were \(\hat\beta=0.20\) in both cases, the approximate Wald statistics would be \(0.20/0.08062=2.48\) and \(0.20/0.1500=1.33\). Using a two-sided standard normal reference, the corresponding approximate p-values are 0.013 and 0.182. The weaker-information design produces a less precise estimate and a less powerful test, even though the assumed coefficient and covariate spread are unchanged. These p-values are illustrations under the stated approximation, not guaranteed results from a fitted population model.

Worked Example: Why Candidate Rankings Can Reflect Precision

Suppose two hypothetical candidate covariates are assessed with one-degree-of-freedom Wald tests in a large-sample approximation. Candidate A has an estimated coefficient of 0.18 and standard error 0.10; candidate B has an estimated coefficient of 0.12 and standard error 0.05. Assume the coefficients use comparable scales and the tests are otherwise valid.

For candidate A, \(z=0.18/0.10=1.80\), giving a two-sided normal-approximation p-value of about 0.0719. For candidate B, \(z=0.12/0.05=2.40\), giving a p-value of about 0.0164. Candidate B ranks ahead by p-value, although its estimated coefficient is smaller. Its greater precision, not a larger estimated effect, accounts for the stronger test statistic.

This ranking does not establish that B is more clinically important or more likely to be a true covariate. The comparison is meaningful only if the effect scales and model specifications are interpretable and the uncertainty estimates are credible. If A’s standard error is large because its subjects have sparse individual information, its lower rank may reflect that limitation rather than compelling evidence that its effect is absent.

Worked Example: Information Imbalance Across Covariate Groups

Consider eight hypothetical subjects with a binary contrast coded \(z_i=+1\) or \(-1\), four in each group. Let \(\omega^2=0.09\). Four subjects have more informative observations, so \(s_i^2=0.04\) and \(w_i=1/0.13=7.692\). The other four have \(s_i^2=0.36\) and \(w_i=1/0.45=2.222\).

First suppose each covariate group contains two more-informative and two less-informative subjects. Each group then has total weight \(2(7.692)+2(2.222)=19.83\), so the weighted covariate mean is zero. The slope information is:

I_{\beta\mid a} =\sum_i w_i(z_i-0)^2 =4(7.692)+4(2.222) =39.66, \qquad SE(\hat\beta)\approx\frac{1}{\sqrt{39.66}}=0.1588.

Now suppose all four more-informative subjects have \(z_i=+1\), while all four less-informative subjects have \(z_i=-1\). The group weights are \(W_+=4(7.692)=30.77\) and \(W_-=4(2.222)=8.889\). For two groups separated by two covariate units, the weighted slope information after fitting the intercept is:

I_{\beta\mid a} = \frac{W_+W_-}{W_++W_-}(2)^2 = \frac{(30.77)(8.889)}{30.77+8.889}(4) =27.58.

The standard error is now approximately \(1/\sqrt{27.58}=0.1904\). Although the number of subjects and the overall counts in each covariate group are unchanged, the effect estimate is less precise because information is unevenly distributed across the groups. This example illustrates why a sample count alone cannot describe the information available for a covariate contrast.

Power, Candidate Ordering, and Model Fitting

For a prespecified one-coefficient test, a Wald statistic is \(\hat\beta/SE(\hat\beta)\). If the null hypothesis is \(H_0:\beta=0\), the alternative is two-sided, and the estimate is approximately normal, rejecting when the absolute statistic exceeds the appropriate critical value controls the test’s nominal type I error under the model assumptions. Lower information increases the standard error and generally lowers power for a fixed nonzero effect. It does not change the definition of the effect or prove that the effect is smaller.

The approximation also clarifies why rankings across candidate covariates require care. Candidates may differ in their observed range, distribution across subjects, correlation with other covariates, or overlap with informative sampling patterns. Their coefficients may also be on different scales. A smaller p-value can reflect a larger effect, better precision, or both. A ranking by p-value alone is therefore not a ranking of effect size or clinical importance.

In a fitted population model, the appropriate main approach is to estimate covariate effects from the marginal likelihood of the concentration data, integrating over individual random effects. The information in those data is then informed by the full model and design. Regressing empirical Bayes estimates on covariates as if they were observed without error is a less defensible shortcut: weak individual information can cause shrinkage and distort the apparent relationship. The earlier material on eta shrinkage bias in covariate screening addresses that particular risk; here the broader point is that sparse information can also make a correctly specified population-level effect imprecise.

A Bayesian analysis with shrinkage priors offers another way to regularize weakly informed coefficients, but the resulting estimates depend on the prior as well as the data. Neither regularization nor a more elaborate search can create information absent from the design. For a planned study, design-based power calculations or simulation can assess the consequences of plausible sampling schedules and covariate distributions; their conclusions remain conditional on the assumed model and parameter values.

Diagnostics and Failure Modes

When a covariate effect is imprecise, inspect the source of the uncertainty rather than treating a nonsignificant test as a complete explanation. Useful checks include:

Sampling information: examine whether sample times and numbers are informative for the parameter linked to the covariate. Sparse samples at similar or uninformative times may yield weak individual information.
Information across covariate values: compare the distribution of covariate values with the distribution of sampling designs and parameter uncertainty. A group with systematically poorer information can weaken a contrast.
Covariate spread and dependence: check whether the covariate varies enough and whether collinearity or confounding with other model components inflates uncertainty.
Fit and uncertainty diagnostics: examine standard errors, likelihood profiles, parameter correlations, convergence, and sensitivity to plausible modeling choices. A flat or irregular likelihood profile can indicate that a local standard-error approximation is unreliable.

These checks cannot identify every form of model misspecification. A poor structural model or an incorrect residual-error model can make nominal standard errors and tests misleading, even when the optimizer converges. Likewise, the simple weighted approximation assumes a linear effect on the selected scale and independent normal errors; it should not be used as an exact correction when those conditions fail.

Approach	What it uses	Main caution under sparse information
Marginal population-model fit	Concentration data and the specified population model, integrating over individual effects	Precision depends on model adequacy, design, covariate variation, and other estimated parameters.
Regression on individual empirical Bayes estimates	Subject-level estimates treated as regression outcomes	Unequal uncertainty and shrinkage can distort screening results; estimates are not error-free observations.
Bayesian shrinkage for covariate coefficients	Likelihood information combined with prior regularization	Weak data may leave posterior estimates sensitive to prior assumptions.

Common mistake: “The candidate with the larger p-value has the smaller covariate effect.” This conclusion confuses effect magnitude with precision. A larger p-value can arise from a smaller estimate, a larger standard error, or both. Compare effect estimates on interpretable scales and examine their uncertainty and information support before describing one candidate as weaker.

Key takeaway: Sparse individual information can widen covariate-effect uncertainty and reduce test power, but its impact depends on how information is distributed across covariate values and on the rest of the model. Candidate rankings should be interpreted as rankings of evidence under specified models and data, not as automatic rankings of effect size or clinical importance.

Check Your Understanding

Answer each question, then check the solutions below.

In the working approximation, what happens to \(w_i\) when \(s_i^2\) increases, and what is the expected consequence for covariate-effect precision?
A candidate has \(\hat\beta=0.15\) and \(SE(\hat\beta)=0.075\). Calculate its Wald statistic. What does that statistic alone say about its effect size relative to another candidate?
Why can two studies with the same number of subjects in each covariate group have different precision for a group contrast?
Name two diagnostics that could help explain an imprecise covariate effect in a population PK model.

Solutions: (1) Since \(w_i=1/(\omega^2+s_i^2)\), increasing \(s_i^2\) decreases \(w_i\). The subject contributes less information, which can increase the coefficient’s standard error, depending on the other subjects and covariate distribution. (2) The statistic is \(0.15/0.075=2.00\). It measures the estimate relative to its uncertainty; by itself it does not show whether the coefficient is larger or smaller than another candidate’s effect. (3) The precision depends on the information weights across covariate values, not only group counts. If one group has systematically less informative observations, its lower total weight can reduce the information for the contrast. (4) Examples include checking sampling times and parameter identifiability, comparing information across covariate values, examining covariate collinearity, and inspecting likelihood profiles or parameter correlations.